CBD Life Sciences Inc. SEC filings CBDL
CBD Life Sciences Inc. has 82 filings in SEC EDGAR's recent list, going back to May 22, 2019. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| QUALIF | Filing | Jun 8, 2026 | — |
| CORRESP | Letter to the SEC | Jun 4, 2026 | — |
| UPLOAD | Letter from the SEC | May 21, 2026 | — |
| 1-A | Filing | May 15, 2026 | — |
| 253G2 | Form 253g2 | May 19, 2025 | — |
| QUALIF | Filing | Mar 19, 2025 | — |
| CORRESP | Letter to the SEC | Mar 18, 2025 | — |
| CORRESP | Letter to the SEC | Mar 17, 2025 | — |
| 1-A POS | Filing | Mar 17, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| 1-A POS | Filing | Mar 6, 2025 | — |
| 1-U | Form 1-u | Jan 22, 2025 | Jan 22, 2025 |
| 253G2 | Filing | Sep 19, 2024 | — |
| QUALIF | Filing | Sep 17, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| CORRESP | Letter to the SEC | Sep 6, 2024 | — |
| 1-A POS | Filing | Sep 6, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2024 | — |
| 1-A POS | Filing | Aug 19, 2024 | — |
| 253G1 | Filing | Jun 24, 2024 | — |
| QUALIF | Filing | Jun 21, 2024 | — |
| CORRESP | Letter to the SEC | Jun 18, 2024 | — |
| 1-A/A | Filing | Jun 18, 2024 | — |
| CORRESP | Letter to the SEC | Jun 17, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2024 | — |
| CORRESP | Letter to the SEC | Jun 5, 2024 | — |
| 1-A/A | Filing | Jun 5, 2024 | — |
| UPLOAD | Letter from the SEC | May 29, 2024 | — |
| 1-A | Filing | May 2, 2024 | — |
| 1-Z | Filing | May 1, 2024 | — |
| 1-U | Form 1-u | Jan 8, 2024 | Dec 11, 2023 |
| 253G1 | Form 253g1 | Aug 29, 2022 | — |
| QUALIF | Filing | Aug 26, 2022 | — |
| CORRESP | Letter to the SEC | Aug 24, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2022 | — |
| 1-A | Filing | Aug 18, 2022 | — |
| 1-Z | Filing | Aug 18, 2022 | — |
| 253G2 | Form 253(g)(2) | Jan 25, 2022 | — |
| 253G2 | Prospectus supplement | Sep 1, 2021 | — |
| 253G2 | Prospectus supplement | Jul 20, 2021 | — |
| QUALIF | Filing | Jul 13, 2021 | — |
| 1-A POS | Filing | Jun 29, 2021 | — |
| QUALIF | Filing | Feb 8, 2021 | — |
| CORRESP | Letter to the SEC | Feb 5, 2021 | — |
| CORRESP | Letter to the SEC | Feb 5, 2021 | — |
| 1-A POS | Filing | Feb 5, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2021 | — |
| 1-A POS | Filing | Jan 22, 2021 | — |
| QUALIF | Filing | Nov 20, 2020 | — |
| CORRESP | Letter to the SEC | Nov 19, 2020 | — |
| CORRESP | Letter to the SEC | Nov 17, 2020 | — |
| 1-A POS | Filing | Nov 17, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2020 | — |
| CORRESP | Letter to the SEC | Nov 3, 2020 | — |
| 1-A POS | Filing | Nov 3, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2020 | — |
| 1-A POS | Filing | Sep 23, 2020 | — |
| 1-K | Filing | Apr 29, 2020 | Dec 31, 2019 |
| QUALIF | Filing | Mar 11, 2020 | — |
| CORRESP | Letter to the SEC | Mar 6, 2020 | — |
| CORRESP | Letter to the SEC | Mar 5, 2020 | — |
| CORRESP | Letter to the SEC | Feb 27, 2020 | — |
| 1-A/A | Filing | Feb 27, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2020 | — |
| 1-A/A | Filing | Feb 25, 2020 | — |
| 1-A/A | Filing | Feb 21, 2020 | — |
| 1-A/A | Filing | Feb 14, 2020 | — |
| CORRESP | Letter to the SEC | Feb 11, 2020 | — |
| 1-A/A | Filing | Feb 11, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2020 | — |
| CORRESP | Letter to the SEC | Jan 15, 2020 | — |
| 1-A/A | Filing | Jan 15, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2019 | — |
| CORRESP | Letter to the SEC | Oct 17, 2019 | — |
| 1-A/A | Filing | Oct 17, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2019 | — |
| 1-A/A | Filing | Sep 23, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2019 | — |
| 1-A/A | Filing | Aug 7, 2019 | — |
| UPLOAD | Letter from the SEC | May 28, 2019 | — |
| 1-A | Filing | May 22, 2019 | — |
Showing 82 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CBDL (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Scottsdale, AZ
- SEC CIK
- 1776073
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.